Skingenix, Inc.
Clinical trials sponsored by Skingenix, Inc., explained in plain language.
-
Can a special ointment heal diabetic foot ulcers faster?
Disease control CompletedThis study tested whether a topical ointment called MEBO can safely and effectively heal diabetic foot ulcers compared to standard care. 75 adults with diabetic foot ulcers lasting at least 4 weeks took part. The main goal was to see if the ulcer healed completely.
Phase: PHASE2 • Sponsor: Skingenix, Inc. • Aim: Disease control
Last updated Jun 22, 2026 12:00 UTC
-
New ointment shows promise for diabetic foot wounds
Disease control CompletedThis study tested a special ointment called MEBO on diabetic foot ulcers. Seven adults with diabetes and foot sores that had not healed for at least 4 weeks took part. The goal was to see if MEBO helps the sores heal completely compared to standard wound care.
Phase: PHASE2 • Sponsor: Skingenix, Inc. • Aim: Disease control
Last updated Jun 17, 2026 12:05 UTC
-
New ointment shows promise for stubborn leg sores
Symptom relief CompletedThis study tested a wound ointment called MEBO on people with venous leg ulcers, which are slow-healing sores on the lower leg. Five adults were randomly assigned to receive either MEBO or standard wound care for up to 8 weeks. The main goal was to see if the ointment helped the …
Phase: PHASE2 • Sponsor: Skingenix, Inc. • Aim: Symptom relief
Last updated Jun 18, 2026 11:52 UTC